Microangiopathic hemolytic anemia in a patient with recurrent anal cancer and liver metastasis

Kun Yun Yeh, Po Dunn, John Wen Cheng Chang, Chuang Chi Liaw*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

6 Scopus citations

Abstract

Microangiopathic hemolytic anemia (MAHA) is a late but fatal complication in advanced cancers (cancer-associated). It may also appear in complete remission after chemotherapy (chemotherapy-related). Mucin-producing adenocarcinoma has been extensively studied in relation to this phenomenon. Squamous cell carcinoma with MAHA, on the other hand, has not often been reported in the English literature. Because of the difficulty of case collection, understanding of the association of MAHA and anal squamous cell carcinoma remains vague. We present a 60-year-old woman with anal cancer and liver metastasis. This patient received chemotherapy (mitomycin C, 5-fluoruracil, and cisplatin) and reached a good partial response. MAHA developed 2 months later, and tumor recurrence with rapid deterioration appeared 5 months later. The patient died 5 months after MAHA was diagnosed. We consider that the MAHA in this patient is chemotherapy-related. However, the possibility of cancer-associated MAHA could not be excluded.

Original languageEnglish
Pages (from-to)706-710
Number of pages5
JournalChang Gung Medical Journal
Volume25
Issue number10
StatePublished - 01 10 2002
Externally publishedYes

Keywords

  • Anal cancer
  • MAHA
  • Mitomycin C

Fingerprint

Dive into the research topics of 'Microangiopathic hemolytic anemia in a patient with recurrent anal cancer and liver metastasis'. Together they form a unique fingerprint.

Cite this